米尔科RNAs可以预测和调节白血病患者对化疗的反应
Doha El-Sayed Ellakwa1,2, Mohamed Ahmed Abdelmalek3, Mostafa M Mostafa4
1Department of Biochemistry and Molecular Biology, Faculty of Pharmacy for Girls, Al-Azhar University, Cairo, Egypt. profdoha@gmail.com.
Naunyn-Schmiedeberg's archives of pharmacology
|January 14, 2025
概括
微RNAs (miRNAs) 显示出作为治疗点和白血病诊断指标的前景. 这些小RNAs调节基因表达并影响癌症的进展,为白血病患者的护理提供了新的见解.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 白血病包括各种血液和骨髓癌,有效治疗方法有限,复发频繁.
- 微RNAs (miRNAs) 是小型非编码RNAs,它们调节基因表达,表观遗传学和细胞功能,如细胞亡和血管生成.
- 白血细胞成熟的遗传异常导致白血病中不受控制的增殖和减少细胞死亡.
研究的目的:
- 审查目前关于白血病中微RNAs的研究.
- 检查miRNAs在癌症进展和扩散中的作用.
- 探索miRNAs作为白血病的诊断标记物和治疗点的潜力.
主要方法:
- 关于微RNA和白血病的研究的文献综述.
- 对miRNA参与瘤发生,瘤抑制和细胞过程的分析.
- 整合miRNA功能与白血病患者护理策略.
主要成果:
- 微RNAs显著调节关键的癌症相关过程,包括血管生成,迁移,亡和基因表达.
- 有证据表明miRNAs影响白血病对化疗的反应.
- 在白血病中,MiRNAs参与激活瘤基因和关闭瘤抑制基因.
结论:
- 微RNAs代表了有希望的治疗点和白血病的诊断指标.
- 了解miRNA功能为白血病检测和管理提供了新的见解.
- 在白血病的发展,进展和治疗反应中,miRNAs起着至关重要的作用.
关键词:
血管新生的产生.细胞灭亡 (apoptosis) 是一种死亡的过程.药物敏感性 药物敏感性在白血病中,白血病.微RNAs是一种微RNA.预测性生物标志物 预测性生物标志物它的治疗潜力很大.治疗耐药性是一种治疗性耐药性.更多相关视频
相关概念视频
MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147


